News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • UBS trims Eurozone 2026 GDP to 0.8% and cuts S&P 500 2026 targets, citing higher oil and Iran conflict risks.
  • CMS increases 2027 Medicare Advantage payment rates, adding about $13 billion and lifting U.S. insurer shares in premarket trading.
  • Philippine annual inflation rose to 4.1% in March as fuel-driven transport costs climbed, pressuring the central bank before its April 23 meeting.
  • Japan's coincident economic indicator fell in February as semiconductor and auto shipments weakened and small-firm bankruptcies rose.
  • Goldman flags the technology sector as a buying opportunity amid low valuations, AI investment, and strong IT earnings expectations.
  • Analysts recommend buying Domino's and StoneCo after recent pullbacks and company-level earnings or cash-flow strength.

Latest Articles

CPS Announces Credit Facility Capacity Increase

CPS Announces Credit Facility Capacity Increase

Consumer Portfolio Services, Inc. has amended its revolving credit agreement with Capital One, increasing the facility capacity from $167.5 million to $390 million. The two-year revolving credit line, secured by auto receivables, allows CPS to borrow on a revolving basis through October 2027, supporting the company's specialty auto finance operatio…

Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development

Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development

Biodesix, Inc. announced it will present seven abstracts, including two oral sessions, at the American Association for Cancer Research (AACR) Annual Meeting. The presentations will showcase the company's innovations in blood- and tissue-based testing, tumor and immune profiling technologies, and a novel multi-omic approach to molecular residual dis…

Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Celldex Therapeutics has closed its underwritten public offering of common stock, including full exercise of underwriters’ option, resulting in gross proceeds of approximately $345 million. The offering was conducted under an existing shelf registration with the SEC. The funds are aimed to support the advancement of Celldex's clinical-stage pipelin…

OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data

OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data

OneMedNet Corporation announced robust financial results for 2025, including a 329% year-over-year revenue increase driven by its AI-driven iRWD™ platform powered by Palantir Foundry. The company has reduced total liabilities by 74%, improved its equity position significantly, and secured promising pilot and subscription opportunities, projecting s…

Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer

Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer

Oncolytics Biotech Inc. announced a scheduled Type C meeting with the FDA to discuss a potential registrational single-arm pivotal study evaluating pelareorep combined with checkpoint inhibitors in second-line and later squamous cell anal carcinoma (SCAC) patients. This study aims to support full approval using objective response rate as the primar…

The Oncology Institute Names Minh Merchant Chief Legal Officer

The Oncology Institute Names Minh Merchant Chief Legal Officer

The Oncology Institute, a publicly traded oncology care provider, announced the hiring of Minh Merchant as Chief Legal Officer. Merchant brings over 20 years of healthcare legal expertise to oversee the company's legal, regulatory, compliance, and privacy functions, supporting its expansion as a leading value-based oncology group serving approximat…

TalentAlly, a Subsidiary of Professional Diversity Network, Inc., Launches Next-Generation Career Fair Hiring Platform Powered by ByteCompute.ai

TalentAlly, a Subsidiary of Professional Diversity Network, Inc., Launches Next-Generation Career Fair Hiring Platform Powered by ByteCompute.ai

Professional Diversity Network, Inc. (Nasdaq: IPDN) announced that its subsidiary, TalentAlly, has launched a next-generation virtual hiring platform powered by ByteCompute.ai. The platform offers advanced features such as pre-event candidate targeting, real-time multi-channel engagement, and comprehensive analytics to improve recruiting outcomes a…

AtlasClear Holdings Begins Onboarding of Third Correspondent Broker-Dealer and Executes Clearing Agreement with Fourth Correspondent Broker-Dealer Through Wilson-Davis

AtlasClear Holdings Begins Onboarding of Third Correspondent Broker-Dealer and Executes Clearing Agreement with Fourth Correspondent Broker-Dealer Through Wilson-Davis

AtlasClear Holdings announced the onboarding of a third correspondent broker-dealer to its clearing platform via its subsidiary Wilson-Davis and executed a clearing agreement with a fourth introducing broker-dealer. The company has enhanced its clearing infrastructure, shortened onboarding times, expanded operations staff, and demonstrated scalabil…

Nexxen Launches AI-Native DSP UI, with Major Enhancements to the nexAI DSP Assistant to Amplify Full-Funnel Outcomes

Nexxen Launches AI-Native DSP UI, with Major Enhancements to the nexAI DSP Assistant to Amplify Full-Funnel Outcomes

Nexxen has launched a new AI-native user interface for its demand-side platform (DSP) along with major enhancements to its nexAI DSP Assistant. These upgrades extend the assistant's capabilities to include pre-campaign setup, troubleshooting, and mid-campaign optimization while maintaining user control and transparency. The AI-driven improvements a…

Diamondback Energy, Inc. Announces Launch of Tender Offers for Any and All of its Outstanding 4.400% Senior Notes due 2051 and 4.250% Senior Notes due 2052

Diamondback Energy, Inc. Announces Launch of Tender Offers for Any and All of its Outstanding 4.400% Senior Notes due 2051 and 4.250% Senior Notes due 2052

Diamondback Energy, Inc., a NASDAQ-listed independent oil and natural gas company, has commenced tender offers to repurchase all outstanding 4.400% Senior Notes due 2051 and 4.250% Senior Notes due 2052 for cash. The offers, expiring April 10, 2026, allow holders to tender notes for purchase with accrued interest, subject to terms outlined in the O…

Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing

Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing

Akari Therapeutics announced a strategic partnership with WuXi XDC to accelerate development of its novel PH1 payload, an RNA splicing modulating antibody drug conjugate (ADC) currently being developed for metastatic urothelial cancer. The collaboration aims to fast-track the first-in-human clinical trial of Akari's lead candidate AKTX-101, leverag…